Finnish dentistry-to-elderly care player Mediverkko and acute care-to-elderly care group Mehilainen are to merge to create a group with sales of €400m in 2014. We talk to the new CEO Mediverkko’s Janne Jarvenpaa.
Hospital Corporation of America will not now have to divest any of its six large and lucrative London hospitals it operates after a humiliating climbdown from the Competition and Markets Authority.
After a traumatic couple of years, the German diagnostic lab sector has set up a new body, Akkreditierte Labore in der Medizin (ALM), to represent its interests. We look at the lobbying sector for diagnostic labs on Europe and the prospects of lab reform in Germany.
As revealed exclusively by Healthcare Europa three weeks ago, financing for the first operator led public-private partnership (PPP) in Poland has been finalised after a three-year process. Several more deals are already in the pipeline in Poland and Slovakia. Healthcare Europa journalist Rhiannon Williams speaks to Nasser Massoud of InterHealth Canada, the Toronto-based international healthcare management company that won the 30-year contract, about the deal and the future of PPPs.
A single Dutch buying agency for nursing homes looks likely says consultant Willem Koelewijn at Koelewijn Zorg. The move should lead to a more informed central buyer with a greater appreciation of care quality.
Lab diagnostics remains a Cinderella sector. At approximately 2% of healthcare expenditure in most West European countries, it is too small to be of interest to the powerful sales forces and lobbyists from big pharma and big medtech.
German medtech and homecare group B Braun has halved its 18% stake in Rhoen Klinikum, the German hospital group, where it had built up a large stake to protect its medtech sales from rival bidder Fresenius. But who has bought the shares?
Amedes, the big German-Belgian lab group, owned by General Atlantic, which failed to sell earlier in 2014, has yet to appoint a new CEO to replace Juerg Debatin who quit in June.
The Krankenkassen, the German statutory insurers, face brave new world of price deregulation. Meanwhile, technical medicine (imaging, labs) may face a tariff cut, whilst hospitals could get extra subsidies and are enjoying another hike in the DRG rate.
Vedici, the French private hospital group where private equity house CVC has a 60% stake, is buying the Polyclinic de la Manche at Saint-Lô and the Clinique du Parc at Caen. The properties are being bought by a French REIT. We hear there was serious competition.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
